Safety and Tolerability of MA09-hRPE Cells in Patients With Stargardt's Macular Dystrophy(SMD)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
CHABiotech CO., Ltd
ClinicalTrials.gov Identifier:
NCT01625559
First received: June 18, 2012
Last updated: February 16, 2015
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)